We are live on ! Find out more
BIVI icon

BioVie

53 hedge funds and large institutions have $8.29M invested in BioVie in 2023 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 21 increasing their positions, 4 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

425% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 4

280% more call options, than puts

Call options by funds: $759K | Put options by funds: $200K

50% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 12

43% more capital inflows, than outflows

Capital inflows: $5.88M | Capital outflows: $4.12M

13% more funds holding

Funds holding: 47 → 53 (+6)

0.75% more ownership

Funds ownership: 4.55% → 5.3% (+0.75%)

Holders
53
Holders Change
+6
Holders Change %
+12.77%
% of All Funds
0.83%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
21
Reduced
4
Closed
12
Calls
$759​K
Puts
$200​K
Net Calls
+$559​K
Net Calls Change
+$565​K

BIVI Hedge Fund Activity: Q2 2023 in Review

53 of the 6,391 institutional investors tracked by Wall St. Rank reported a position in BioVie (BIVI) for Q2 2023, worth a combined $8.29M — down 36% from $13M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new BIVI positions and 12 closed out — a net gain of 6 holders — while 21 added to existing stakes and 4 trimmed.

The largest buyer was Millennium Management, adding an estimated $2.02M. The largest seller was Invesco, exiting entirely with an estimated $1.56M sold.

  • 53 institutional investors held BioVie (BIVI) as of Q2 2023, up from 47 in Q1 2023.
  • Funds reported $8.29M of BioVie stock for Q2 2023, down 36% quarter-over-quarter.
  • 18 funds opened new BioVie positions in Q2 2023 and 12 closed out, a net change of +6 holders.
  • The largest BioVie buyer in Q2 2023 was Millennium Management, an estimated $2.02M added.
  • The largest BioVie seller in Q2 2023 was Invesco, an estimated $1.56M sold.

Based on aggregated 13F filings for Q2 2023.